Evista and Hair texture abnormal - a phase IV clinical study of FDA data

Summary:

Hair texture abnormal is reported as a side effect among people who take Evista (raloxifene hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Taxotere, and have Breast cancer female.

The phase IV clinical study analyzes which people have Hair texture abnormal when taking Evista. It is created by eHealthMe based on reports of 25,442 people who have side effects when taking Evista from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Hair texture abnormal?

Hair texture abnormal is found to be associated with 729 drugs and 655 conditions by eHealthMe. Check the latest studies of Hair texture abnormal.

On Jul, 13, 2026

25,442 people reported to have side effects when taking Evista.
Among them, 26 people (0.1%) have Hair texture abnormal.

Could Evista cause Hair texture abnormal?

Among these 26 people:

How long have people been on Evista when they have Hair texture abnormal? *

What is the gender of people who have Hair texture abnormal when taking Evista? *

female: 100 %
male: 0.0 %

What is the age of people who have Hair texture abnormal when taking Evista? *

What are other drugs people take besides Evista? *

What are other side effects people have besides Hair texture abnormal? *

Hair Loss: 16 people, 61.54%
Hair Color Changes: 10 people, 38.46%
Hair Disorder: 8 people, 30.77%
Swallowing Difficulty: 4 people, 15.38%
Hot Flush (sudden feelings of heat): 3 people, 11.54%
Injection Site Bruising: 3 people, 11.54%
Blood Glucose Decreased: 3 people, 11.54%
Cough: 3 people, 11.54%
Hair Growth Abnormal: 3 people, 11.54%
Fainting (loss of consciousness and postural tone): 3 people, 11.54%

What are the existing conditions these people have? *

Breast Cancer Female: 6 people, 23.08%
Hair Loss: 2 people, 7.69%
Breast Cancer Metastatic: 2 people, 7.69%
High Blood Cholesterol: 2 people, 7.69%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 3.85%
Blood Pressure Abnormal: 1 person, 3.85%
Bone Development Abnormal: 1 person, 3.85%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 3.85%
Constipation: 1 person, 3.85%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Hair texture abnormal?

- Check whether Hair texture abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evista:

Evista (25,891 reports)

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair texture abnormal:

Hair texture abnormal (729 drugs)

Browse all the conditions that are associated with Hair texture abnormal:

Hair texture abnormal (655 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.